IPO registrations (S-1, F-1) · Registrants

VOLITIONRX LTD

SEC CIK
93314 · filings on EDGAR ↗
Former names
STANDARD CAPITAL CORP (1999–2011)
Registration
Form S-1, first filed 2012-08-03, last 2025-04-04; 4 initial registrations, 6 amendments
Outcome
Final prospectus filed 2015-02-09; declared effective 2012-10-25; withdrawal requested 2025-04-16
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances 2835
Incorporated in
DE
Business address
1489 WEST WARM SPRINGS ROAD, SUITE 110, Henderson, NV 89014
EIN
91-1949078
Ticker
VNRX (NYSE)
EDGAR entity type
operating
Insiders and CEO pay
VOLITIONRX LTD on the corporate pages

Offering terms

Final price
$3.75 per share (424B4 filed 2015-02-09)
Shares sold
2,475,000
Gross proceeds
$9,281,250 before underwriting discounts and any over-allotment option
Listing
OTCQB under the symbol VNRX
Lead underwriters
The Benchmark Company (247,500 shares)
Syndicate
Lake Street Capital Markets (866,250); National Securities Corporation (1,361,250)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 28

FiledFormWhat it isName as filedEDGAR
2012-08-03S-1S-1 (registration)VOLITIONRX LTD0001078782-12-001917 ↗
2012-09-13S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-12-002407 ↗
2012-10-04S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-12-002572 ↗
2012-10-25EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-12-003083 ↗
2014-04-11S-1S-1 (registration)VOLITIONRX LTD0001078782-14-000627 ↗
2014-04-25EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-14-001136 ↗
2014-11-28S-1S-1 (registration)VOLITIONRX LTD0001078782-14-002155 ↗
2015-01-08S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-15-000016 ↗
2015-01-08S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-15-000020 ↗
2015-01-23S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-15-000105 ↗
2015-02-04S-1/AS-1/A (amendment)VOLITIONRX LTD0001078782-15-000164 ↗
2015-02-05EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-15-000306 ↗
2015-02-09424B4424B4 (final prospectus)VOLITIONRX LTD0001078782-15-000181 ↗
2015-06-26EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-15-001750 ↗
2015-09-18EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-15-002543 ↗
2018-09-28EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-18-002505 ↗
2018-10-15EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-18-002627 ↗
2020-02-14EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-20-000376 ↗
2021-11-08EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-21-004240 ↗
2024-06-25EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-24-001953 ↗
2025-04-04S-1S-1 (registration)VOLITIONRX LTD0001477932-25-002474 ↗
2025-04-15EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-25-001124 ↗
2025-04-16RWRW (withdrawal request)VOLITIONRX LTD0001477932-25-002795 ↗
2025-04-18EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-25-001148 ↗
2025-07-14EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-25-002249 ↗
2026-02-19EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-26-000634 ↗
2026-07-17EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-26-002355 ↗
2026-09-09EFFECTEFFECT (declared effective)VOLITIONRX LTD9999999995-26-002936 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-02-04S-1/Aregistration statement$1.75--0primary document; price sentencedocument ↗
2015-02-09424B4final prospectus$3.752,475,000$9,281,250OTCQB VNRX3primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Magallano Alexander B.Director,OfficerChief Executive Officer12011
Perez Rudy BelloyOfficerTreasurer & Secretary12011
Colman AlanDirector312013–2026
Faulkes Martin CharlesDirector; Director,OfficerExecutive Director402013–2024
Innes Guy ArchibaldDirector592013–2026
Lewin Malcolm ThomasOfficerPFO, ACCOUNTING OFFICER, TREAS; PFO, PAO, TREASURER22013–2014
Reynolds Cameron JohnDirector,Officer; Director,Officer,TenPercentOwnerCEO and President; President and CEO; PRESIDENT AND CEO; President & CEO522013–2026
Rootsaert Rodney GerardDirector,Officer; Officer; Officer,TenPercentOwnerSecretary; SECRETARY492013–2026
Concord International Inc.TenPercentOwner12014
Skaff HabibDirector122014–2019
O'Connell Michael JamesOfficerChief Financial Officer12014
KRATOCHVIL DAVID MATTHEWOfficerChief Financial Officer42015–2016
Micallef Jacob VincentOfficerChief Scientific Officer502015–2026
TERRELL JASON BRADLEY MDOfficerChief Medical Officer252016–2022
Futcher EdwardDirector152016–2024
Vanston David CecilOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER82017–2020
Gaetan MichelOfficer; OtherChief Operating Officer222017–2026
Cotterford Co LtdTenPercentOwner32019
Eight Corp LtdTenPercentOwner52019–2024
Barnes PhillipDirector142019–2026
Kway JasmineOfficer; OtherCEO - Singapore Volition; CEO -Singapore Volition; CEO, Singapore Volition; CEO-Singapore Volition212020–2026
Butera Salvatore ThomasDirector; OfficerCEO - Volition Veterinary; CEO Volition Veterinary; CEO, Volition Veterinary; CEO-Volition Veterinary422020–2026
Forterre GaelOfficerChief Commercial Officer; Chief Commerical Officer312021–2026
Hughes TerigOfficerChief Financial Officer202021–2026
Brudnick RichardDirector62021–2023
Nguyen KimDirector182021–2026
Plummer NicholasOfficerGC - Volition Diagnostics; GC Volition Diagnostics; GC, Volition Diagnostics262021–2026
Henshall MickieDirector62022–2026
Batchelor Ann-LouiseOfficerGroup Chief Marketing Officer222022–2026
Hever Investments LtdTenPercentOwner22023–2024
Retter AndrewOfficerChief Medical Officer122024–2025
Rubin EthelDirector82024–2026
STILL TIMOTHY IDirector52024–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-05-30VOLITIONRX LTDBiotechnology$22,650,000$22,650,00012
2024-03-26VOLITIONRX LTDBiotechnology$100,000$100,00011
2018-08-27VOLITIONRX LTDBiotechnology$24,000,000$24,000,00011
2014-11-21VOLITIONRX LTDBiotechnology$721,849$721,849211
2014-10-14VOLITIONRX LTDBiotechnology$750,000$750,000231
2014-10-14VOLITIONRX LTDBiotechnology$229,393$229,393101
2014-09-25VOLITIONRX LTDBiotechnology$1,189,749$1,189,74971
2014-03-11VOLITIONRX LTDBiotechnology$3,000,000$3,000,000241

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationVOLITIONRX LIMITEDNVState business registriesname and state
Form D issuerVOLITIONRX LTDNVForm D private offeringsCIK (EXACT)
SEC filerVOLITIONRX LTDSEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.